ENANTA PHARMACEUTICALS INC - 10-K Filing

Enanta Pharmaceuticals reports fiscal year 2025 financial position including royalty agreement details and pipeline segment disclosures.

SEC EDGAR ·

Tickers: $ENTA

Read the full article at SEC EDGAR

More Regulatory news